NHS England to offer Casgevy for sickle cell disease patients
CRISPR-based gene therapy Casgevy has been made available to patients with sickle cell disease in England.
CRISPR-based gene therapy Casgevy has been made available to patients with sickle cell disease in England.
What's Your Reaction?
